Procurement index drops 1.5%

D&B pointed out that the January figure was still above the 50%, which is the threshold between economic expansion and contraction, and has been so for 15 consecutive months.

By SHARON WROBEL
February 15, 2007 07:08

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Procurement Managers Index fell 1.5 percentage points to 54.4% in January from 55.9% in December, according to Dun and Bradstreet's Israel Purchasing and Logistics Managers Association's index. D&B pointed out that the January figure was still above the 50%, which is the threshold between economic expansion and contraction, and has been so for 15 consecutive months. The index's key components expanded for the 23rd consecutive month, despite a drop of 9.7% in manufacturing and demand for workers in the manufacturing sector in January. Demand for products was mixed, with domestic demand for Israeli products falling while overseas demand for Israeli products rose.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS